`
`————————————————
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`————————————————
`
`ACRUX DDS PTY LTD., ACRUX LIMITED, and
`ARGENTUM PHARMACEUTICALS LLC,
`Petitioners
`
`v.
`
`KAKEN PHARMACEUTICAL CO., LTD. and
`VALEANT PHARMACEUTICALS INTERNATIONAL, INC.
`Patent Owners.
`————————————————
`
`Case: IPR2017-00190
`U.S. Patent No. 7,214,506
`
`————————————————
`
`ACRUX’S UPDATED MANDATORY NOTICES
`
`Pursuant to 37 C.F.R. § 42.8, Petitioners Acrux DDS Pty Ltd. and Acrux
`
`
`
`Limited (“Acrux”), hereby submit the following updated mandatory notices in
`
`connection with this proceeding.
`
`37 C.F.R. § 42.8(b)(3) and (4): Lead and Back-Up Counsel, and
`(a)
`Service Information.
`
`Acrux designates the following counsel to transact all business in the United
`
`States Patent & Trademark Office Associated with
`
`the above-captioned
`
`proceeding.
`
`
`
`
`
`
`
`Lead Counsel
`
`Backu Counsel
`
`Tara M. Raghavan (Reg. No. 55,557)
`traghavan@rmmslegal.com
`Postal and Hand Delivefl Address
`RAKOCZY MOLINO MAZZOCHI SIWIK
`LLP
`6 West Hubbard Street, Suite 500
`Chicago, Illinois 60654
`Tel: (312) 222-6340
`Fax: (312) 222-6341
`
`Steven J. Birkos Gleg. No. 65,300)
`sbirkos@rmmslegal.com
`William A. Rakoczy
`(pro hac vice to be filed)
`wrakoczy@1mmslegal.com
`Joseph T. Jaros
`(pro hac vice to be filed)
`jjaros@rmmslegal.com
`Postal and Hand Delivery Address
`RAKOCZY MOLINO MAZZOCHI SIWIK LLP
`
`6 West Hubbard Street, Suite 500
`
`Fax: (312) 222-6321
`
`Chicago, Illinois 60654
`Tel: (312) 222-5127
`
`Please address all correspondence regarding this proceeding to lead and
`
`back-up counsel.
`
`Dated: September 18, 2018
`
`Respectfully submitted,
`
`By: /s/ Tara M. Raghavan
`Tara M. Raghavan, Reg. No. 55,557
`RAKOCZY MOLINO MAZZOCHI SIWIK LLP
`
`6 W. Hubbard Street, Suite 500
`Chicago, Illinois 60654
`Telephone: (312) 222-6340
`Facsimile:
`(312) 222-6341
`
`Counselfor Acrux DDS Ply Ltd. and Acrux
`Limited
`
`
`
`
`
`
`CERTIFICATE OF SERVICE
`
`The undersigned hereby certifies that a true and correct copy of ACRUX’S
`
`
`
`
`
`UPDATED MANDATORY NOTICES was served on September 18, 2018, via
`
`electronic mail by agreement of the parties, on the following:
`
`John D. Livingstone
`Finnegan, Henderson, Farabow, Garret & Dunner, L.L.P.
`271 17th Street, NW, Suite 1400
`Atlanta, GA 30363-6209
`john.livingstone@finnegan.com
`KakenIPR@finnegan.com
`
`Naoki Yoshida
`naoki.yoshida@finnegan.com
`Anthony Hartman
`anthony.hartman@finnegan.com
`Barbara R. Rudolph, Ph.D.
`barbara.rudolph@finnegan.com
`Finnegan, Henderson, Farabow, Garret & Dunner, L.L.P.
`901 New York Ave., NW
`Washington, DC 20001-4413
`
`Toan P. Vo
`toan.vo@bausch.com
`Valeant Pharmaceuticals North America LLC
`1400 N. Goodman Street
`Rochester, New York 14609
`
`Teresa Staneck Rea
`TRea@Crowell.com
`Shannon M. Lentz
`SLentz@Crowell.com
`Crowell & Moring LLP
`Intellectual Property Group
`1001 Pennsylvania Ave, NW
`Washington, DC 2004-2595
`
`
`
`
`
`
`Tyler C. Liu
`TLiu@agpharm.com
`Argentum Pharmaceuticals, LLC
`
`
`
`Dated: September 18, 2018
`
`
`
`
`
`
`
`
`
`
`
`Respectfully submitted,
`
`By: /s/ Tara M. Raghavan
`Tara M. Raghavan, Reg. No. 55,557
`RAKOCZY MOLINO MAZZOCHI SIWIK LLP
`6 W. Hubbard Street, Suite 500
`Chicago, Illinois 60654
`Telephone: (312) 222-6340
`Facsimile: (312) 222-6341
`
`Counsel for Acrux DDS Pty Ltd. and Acrux
`Limited
`
`
`
`